Martin A. Mattingly is Director at ONCOGENEX PHARMACEUTICALS, INC. (OGXI). They have made 1 open-market trade across 1 company since 2012, most recently 2016-06-01.
CIK 0001265782
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $12K since 2012, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| OGXI | BUY | 2012-06-01 | 2012-06-04 | $12.46 | $12K | -34.8% | +1.7% | +1.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.